|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Disease-modifying activity of SB 242235,a selective inhibitor of p38 mitogen-activated protein kinase,in rat adjuvant-induced arthritis显示文摘 | Badger AM Griswold DE Kapadia R | | 0，，01： | 1 |
| 2 | Pharmacological profde of SB 203580, a selective inhibitor of cytokine suppressive inhibitor binding protein/P38 kinase in animal models of arthritis, bone resorption,endotoxin shock and immune function显示文摘 | Badger AM Bradbeer JN Votta B | 1995 | J Pharmacol Exp Ther1995，279，： | 1 |
| 3 | p38 MAP kinase:molecular target for the inhibition of pro-inflammatory cytokines显示文摘 | JL Adams AM Badger S Kumar | 2001 | Prog Med Chem2001，38，： | 1 |
| 4 | p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines显示文摘 | Adams JL Badger AM Kumar S | | 0，，： | 1 |
| 5 | 显示文摘 | Badger AM Bradbeer JN Votta B | 1996 | Pharmacol Exp Ther1996，279，3： | 1 |
| 6 | Beneficial effects of the phosphodiesterase inhibitors BRL 61063,pentoxifylline,and rolipram in a murine model of endotoxin shock显示文摘 | Badger AM DL O Esser Km | 1994 | Circ Shock1994，44，： | 1 |
| 7 | Regulation of fatty acid synthase显示文摘 | Badger AM Newman-Tarr TM Satterfield JL | 1997 | Prog Lipid Res1997，36，： | 1 |
| 8 | Pharmacological profile of SB203580,a selective inhibitor of cytokine suppressive binding protein/p38 kinase,in animal model of arthritis,bone resorption,endotoxin shock and immune function显示文摘 | Badger AM Bradbeer JN Vatta B | 1996 | J Pharmacol Exp Ther1996，279，： | 1 |
| 9 | Pharmacological profile of SB203580,a selective inhibitor of cytokine suppressive binding protein/p38 kinase,in animal models of arthritis,bone resorption,endotovin shock and immune funtion显示文摘 | Badger AM Bradbeer JN Votta B | 1996 | J Pharmacol Exp Ther1996，279，3： | 1 |
| 10 | Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorp tion, endotovin shock and immune funtion 显示文摘 | Badger AM Bradbeer JN Votta B | 1996 | J Pharmacol Exp Ther1996，279，3： | 1 |
| 11 | SB 203580 inhibits p38 mitogen-activated protein kinase,nitric oxide production,and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes显示文摘 | Badger AM Cook MN Lark MW | | 0，，01： | 1 |
| 12 | Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product,hymenialdisine显示文摘 | Badger AM Cook MN Swift BA | 1999 | J Pharmacol Exp Ther1999，290，2： | 1 |
| 13 | Applications of micro-CT and MR microscopy to study pre-clinieal models of osteoporosis and osteoarthritis 显示文摘 | Kapadia RD Stroup GB Badger AM | 1998 | Technol Health Care1998，6，56： | 1 |
| 14 | p38 MAP kinase:molecular target for the inhibition of pro-inflammatory cytokines显示文摘 | Adams JL Badger AM Kumar S | 2001 | Prog Med Chem2001，38，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员